載入...
Rosiglitazone activation of PPARγ suppresses fractalkine signaling
The nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) is a key transcriptional regulator of both lipid metabolism and inflammation. The importance of PPARγ is accentuated by the widespread use of synthetic PPARγ agonists, thiazolidinediones (such as rosiglitazone), as drugs for i...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Society for Endocrinology
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2805405/ https://ncbi.nlm.nih.gov/pubmed/19850645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1677/JME-09-0090 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|